EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS020-09742 
Organism
Homo sapiens 
Tissue/cell
CD34+ 
Coordinate
chr12:10391620-10393340 
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs12303774chr1210392484hg19
TF binding sites/motifs
Number: 48             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr12:10392082-10392100TCTTCCTTCCTTCCTTCC-10.05
EWSR1-FLI1MA0149.1chr12:10392031-10392049CTTTCCTTCCTTCCTTCC-10.53
EWSR1-FLI1MA0149.1chr12:10392035-10392053CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392039-10392057CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392043-10392061CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392047-10392065CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392051-10392069CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392055-10392073CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392059-10392077CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392063-10392081CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392086-10392104CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr12:10392071-10392089CCTTCCTTCCTTCTTCCT-6.71
EWSR1-FLI1MA0149.1chr12:10392027-10392045CTTCCTTTCCTTCCTTCC-6.98
EWSR1-FLI1MA0149.1chr12:10392022-10392040CCTTCCTTCCTTTCCTTC-7.26
EWSR1-FLI1MA0149.1chr12:10392078-10392096TCCTTCTTCCTTCCTTCC-7.2
EWSR1-FLI1MA0149.1chr12:10391998-10392016ATTTCCTTCCTTCCTTCT-7.43
EWSR1-FLI1MA0149.1chr12:10392006-10392024CCTTCCTTCTTTCCATCC-7.73
EWSR1-FLI1MA0149.1chr12:10392010-10392028CCTTCTTTCCATCCTTCC-7.74
EWSR1-FLI1MA0149.1chr12:10392098-10392116CCTTCCCTCCTTCCCTCC-7.85
EWSR1-FLI1MA0149.1chr12:10392018-10392036CCATCCTTCCTTCCTTTC-8.35
EWSR1-FLI1MA0149.1chr12:10392014-10392032CTTTCCATCCTTCCTTCC-8.46
EWSR1-FLI1MA0149.1chr12:10392067-10392085CCTTCCTTCCTTCCTTCT-9.09
EWSR1-FLI1MA0149.1chr12:10392002-10392020CCTTCCTTCCTTCTTTCC-9.47
EWSR1-FLI1MA0149.1chr12:10392090-10392108CCTTCCTTCCTTCCCTCC-9.47
EWSR1-FLI1MA0149.1chr12:10392094-10392112CCTTCCTTCCCTCCTTCC-9.93
IRF1MA0050.2chr12:10392655-10392676ACTTTCTTTCTTTTTTTTTTT+6.09
IRF1MA0050.2chr12:10392172-10392193TCTTTCTTTCTTTTTCTTTCT+6.14
ZNF263MA0528.1chr12:10392074-10392095TCCTTCCTTCTTCCTTCCTTC-6.01
ZNF263MA0528.1chr12:10392010-10392031CCTTCTTTCCATCCTTCCTTC-6.13
ZNF263MA0528.1chr12:10392023-10392044CTTCCTTCCTTTCCTTCCTTC-6.23
ZNF263MA0528.1chr12:10392086-10392107CCTTCCTTCCTTCCTTCCCTC-6.24
ZNF263MA0528.1chr12:10392031-10392052CTTTCCTTCCTTCCTTCCTTC-6.48
ZNF263MA0528.1chr12:10392066-10392087TCCTTCCTTCCTTCCTTCTTC-6.48
ZNF263MA0528.1chr12:10392098-10392119CCTTCCCTCCTTCCCTCCCCT-6.62
ZNF263MA0528.1chr12:10392078-10392099TCCTTCTTCCTTCCTTCCTTC-6.63
ZNF263MA0528.1chr12:10392070-10392091TCCTTCCTTCCTTCTTCCTTC-6.76
ZNF263MA0528.1chr12:10392094-10392115CCTTCCTTCCCTCCTTCCCTC-6.8
ZNF263MA0528.1chr12:10392006-10392027CCTTCCTTCTTTCCATCCTTC-6.93
ZNF263MA0528.1chr12:10392035-10392056CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392039-10392060CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392043-10392064CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392047-10392068CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392051-10392072CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392055-10392076CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392059-10392080CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392063-10392084CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr12:10392082-10392103TCTTCCTTCCTTCCTTCCTTC-7.03
ZNF263MA0528.1chr12:10392090-10392111CCTTCCTTCCTTCCCTCCTTC-8.12
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_58798chr12:10364530-10401135Ly1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr121039185510391940
Enhancer Sequence
GCTCAAGAAT TCTAAAAAGC CAGAATGAGG GGATAACTTT CACCAAAGAC TTTTCCTTTA 60
TCTTTTGTTG TACGTGGTCA CTTAACTGTT TTAGCTTAAT TTAACAAAAA AGATGAGAAA 120
ATATTTTTAC AGTATCATGA GATGAGGCTT CTAATGGGCT GGTGGCCAAG GATGGGGAAA 180
AGAATCAAGG ACAGATTAAA TCTCCAAAGT AAGAGAATCT ATTATATAGC AAACAAACTT 240
GTATAATTAA TCTCTAGGAG CACGGGTTCT AATAAGCCCA GGTACCACAA AGATAGAGAA 300
TTGCTTCTTC TGTCCAGGCA AAAGGCATGA CTAAAGGTGT GACTTGCTCT CTGGGGATGA 360
TACCAATTTG GCAGCAGCAT TTCCTTCCTT CCTTCTTTCC ATCCTTCCTT CCTTTCCTTC 420
CTTCCTTCCT TCCTTCCTTC CTTCCTTCCT TCCTTCCTTC CTTCTTCCTT CCTTCCTTCC 480
TTCCCTCCTT CCCTCCCCTT TCTTTCTTTC TTTCTTTCTT TCTTTCTTTC TTTCTTTCTT 540
TCTTTCTTTC TTTCTTTCTT TCTTTTTCTT TCTTTCTTTC TCTCTCTTTC TTTCTTCTTT 600
TCTCTTTCTC TCTGTCTTTT GTTTGTTCGT TCATTTTTGA GACAGAGTCT CACTCTGTTG 660
CCCAGGCTGG AGTGCAGTGG CATGATCTCA GTTCACTGTA ACCTCCACTT CCCGGGTTCA 720
GGCGATTCTC CTGCCTCAGC CTCCTAAGTA GCTGGGATTA CAGGTGCCCG CCATCATGCC 780
CAGCTAATTT TTGTATTTTT ACTAGAGATG GGGTTTCACC ATGTTGGCCA GGCTGGACTT 840
GAACTCCTGA CCTGAAGTGA TCCGCCCGCC TCAGCCTTCC AAAGTGTTGG GATTACAGAC 900
GTGAGCCACT TTTTCTCTTT CTTAAAACAT TTTGCCCAAT GCTAAATTTT ACTGCTTGGT 960
TTCACCATAG TAATCTGCTC TAGAAGAAAA TTACCACAGG TGGGATTGTC AAGGTGTTCC 1020
GGGATAATCA TTTCTACTTT CTTTCTTTTT TTTTTTGGAG ACAGGTTCTT ACTTTGTCAC 1080
CCAGGCTGGA GTGCAGTGGC GTGATCTCAG CTCAATGCAG CCTCAACCTC CCAGGCTCAA 1140
GCTACCTTCT TACCTCAGCC CCCCAAGTCG CTGGGACCAC AGGTGCGCAC CATCATGCTG 1200
GGCTAATTTT TGTATTTTTT GTAGACACAG GGTTTTGCCA TGTTGCCCAG GCTGGTCTTG 1260
AGCTCCTGAG CTCAAGCGAT CTGCCCGCTT CTGCCTCCCA AAGTGCTGGG ATTACAGGCT 1320
GAGTCACCAT GCCCAGCCCT CATTTCTATT TTCTACATGC CTTTTTTTTT TCTTTGCTTT 1380
CATTGTTCAG CTTCATGCCA TGATCTTATT CTGACCATGA TGAAATTAGT AGAATAGATC 1440
TTCACTTACG TTCTCTGCTC CCAGTGACTA ATGTAGAGAC AAGAGTTTTT ATATTATTTG 1500
AATTTTTGTT ATGAAAAAAT GTAAACATTA AGTAATATAG ACATAATAAC TTAATGAACT 1560
ACCATGTGCC CATCACCCAG CTTCAACTCA CTCCCCAATC AAGGTGAGTG TGTATCTCCC 1620
ATGAGTGAGT AAACTACCAC GTGCCCATCA CCCAGCTTCA ACAAGCATCG ACTCACTCTC 1680
CAATCAAGGT GAAATATCAG ACATCATGTG ATTTTATCGG 1720